后颅窝肿瘤术后无症状性脑静脉窦血栓形成:发生率、危险因素及治疗选择
这项回顾性单中心研究纳入2013年1月至2020年12月在半坐位接受后颅窝肿瘤手术的266例患者,术后脑静脉窦血栓形成发生率为12.4%(33/266),均为无症状。多因素分析显示脑膜瘤(P<.001,OR 11.3,95%CI 4.1-31.2)和前庭神经鞘瘤(P=.013,OR 4.4,95%CI 1.3-16.3)是危险因素;治疗性抗凝与更高的颅内出血率相关(n=4,P=.017)。
要点
- 后颅窝肿瘤术后无症状性脑静脉窦血栓形成为12.4%(33/266)。
- 脑膜瘤(OR 11.3)和前庭神经鞘瘤(OR 4.4)是术后血栓形成的危险因素。
- 治疗性抗凝与更高颅内出血率相关(n=4,P=.017)。
核心结论
- 肿瘤类型影响术后脑静脉窦血栓形成的发生率。
- 对于临床无症状的患者,是否启动治疗性抗凝需要谨慎决策。
研究设计与样本
- 回顾性单中心研究,纳入2013年1月至2020年12月在半坐位接受后颅窝肿瘤手术的全部患者,共266例。
- 所有患者术前和术后均行MRI检查,伴或不伴额外CT血管造影。
- 分析人口学和手术数据对术后脑静脉窦血栓形成发生率的影响。
- 考察术后脑静脉窦血栓形成的治疗性抗凝或保守治疗及颅内出血发生率。
主要发现
- 266例患者中33例(12.4%)发生术后脑静脉窦血栓形成,所有患者均无症状。
- 33例中13例接受治疗性抗凝,20例未接受。
- 单因素分析显示年龄(P=.56)、性别(P=.20)、美国麻醉医师学会分级(P=.13)、体重指数(P=.60)和手术时长(P=.176)与术后脑静脉窦血栓形成无统计学相关。
- 多因素分析显示脑膜瘤(P<.001,OR 11.3,95%CI 4.1-31.2)和前庭神经鞘瘤(P=.013,OR 4.4,95%CI 1.3-16.3)是术后新发脑静脉窦血栓形成的危险因素。
- 使用治疗性抗凝治疗术后脑静脉窦血栓形成与更高的颅内出血率相关(n=4,P=.017)。
临床怎么用
- 对于临床无症状的术后脑静脉窦血栓形成患者,是否启动治疗性抗凝需要谨慎决策。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cerebral venous sinus thrombosis (CVST) is a known complication of posterior fossa surgery near the sigmoid and transverse sinus. The incidence and treatment of postoperative asymptomatic CVST are controversial. OBJECTIVE: To analyze incidence, risk factors, and management of asymptomatic postoperative CVST after posterior fossa tumor surgery. METHODS: In this retrospective, single-center study, we included all patients who underwent posterior fossa tumor surgery in the semisitting position between January 2013 and December 2020. All patients underwent preoperative and postoperative imaging using MRI with/without additional computed tomography angiography. We analyzed the effect of demographic and surgical data on the incidence of postoperative CVST. Furthermore, therapeutic anticoagulation or conservative treatment for postoperative CVST and the incidence of intracranial hemorrhage were investigated. RESULTS: In total, 266 patients were included. Thirty-three of 266 (12.4%) patients developed postoperative CVST. All patients were asymptomatic. Thirteen of 33 patients received therapeutic anticoagulation, and 20 patients did not. Univariate analysis showed that age ( P = .56), sex ( P = .20), American Society of Anesthesiology status ( P = .13), body mass index ( P = .60), and length of surgery ( P = .176) were not statistically correlated with postoperative CVST. Multivariate analysis revealed that meningioma ( P < .001, odds ratio 11.3, CI 95% 4.1-31.2) and vestibular schwannoma ( P = .013, odds ratio 4.4, CI 95% 1.3-16.3) are risk factors for the development of new postoperative CVST. The use of therapeutic anticoagulation to treat postoperative CVST was associated with a higher rate of intracranial hemorrhage (n = 4, P = .017). CONCLUSION: Tumor entity influences the incidence of postoperative CVST. In clinically asymptomatic patients, careful decision making is necessary whether to initiate therapeutic anticoagulation or not.
引用
- Shabo E, Wach J, Hamed M, et al. Asymptomatic Postoperative Cerebral Venous Sinus Thrombosis After Posterior Fossa Tumor Surgery: Incidence, Risk Factors, and Therapeutic Options. Neurosurgery. 2023. PMID: 36728332. doi:10.1227/neu.0000000000002340
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。